Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Suzano is the world's largest producer of market pulp and a global leader in the development of sustainable, bio-based solutions derived from eucalyptus forests. The company maintains a significant presence in the biotechnology sector through its subsidiary, FuturaGene, which is a pioneer in plant genomics and genetic engineering aimed at increasing forest productivity and resilience. Beyond its core pulp business, Suzano is expanding into the life sciences and healthcare sectors by producing high-performance fluff pulp for hygiene products and developing lignin-based bioproducts as sustainable alternatives to fossil-based chemicals. The company also operates Suzano Ventures, a corporate venture capital arm that invests in early-stage startups focused on synthetic biology, biomaterials, and carbon management. With a strong commitment to the 'bio-economy,' Suzano integrates advanced R&D with large-scale industrial manufacturing to deliver renewable materials globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Suzano.